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Abstract
Airway epithelial tight junction (TJ) proteins form a resistive barrier to the external
environment, however, during respiratory bacterial infection TJs become disrupted
compromising barrier function. This promotes glucose flux/accumulation into the
lumen which acts as a nutrient source for bacterial growth. Metformin used for the
treatment of diabetes increases transepithelial resistance (TEER) and partially pre-
vents the effect of bacteria but the mechanisms of action are unclear. We investi-
gated the effect of metformin and Staphylococcus aureus on TJ proteins, zonula
occludins (ZO)‐1 and occludin in human airway epithelial cells (H441). We also
explored the role of AMP‐activated protein kinase (AMPK) and PKCζ in metformin‐
induced effects. Pretreatment with metformin prevented the S. aureus‐induced
changes in ZO‐1 and occludin. Metformin also promoted increased abundance of
full length over smaller cleaved occludin proteins. The nonspecific PKC inhibitor
staurosporine reduced TEER but did not prevent the effect of metformin indicating
that the pathway may involve atypical PKC isoforms. Investigation of TJ reassembly
after calcium depletion showed that metformin increased TEER more rapidly and
promoted the abundance and localization of occludin at the TJ. These effects were
inhibited by the AMPK inhibitor, compound C and the PKCζ pseudosubstrate inhibi-
tor (PSI). Metformin increased phosphorylation of occludin and acetyl‐coA‐carboxy-
lase but only the former was prevented by PSI. This study demonstrates that
metformin improves TJ barrier function by promoting the abundance and assembly
of full length occludin at the TJ and that this process involves phosphorylation of
the protein via an AMPK‐PKCζ pathway.
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1 | INTRODUCTION
The airway epithelium of the human respiratory tract acts as the first
physical barrier that protects against inhaled substances and patho-
gens. Epithelial barrier dysfunction during respiratory bacterial infec-
tions is characterized by alterations in tight junction (TJ) protein
abundance.1,2 TJs, the most apically located of the intercellular junc-
tional complexes, regulate the passage of solutes, ions, and macro-
molecules through the paracellular space between epithelial cells. TJs
are formed by three classes of integral transmembrane proteins:
claudins,3 occludins,4 and junctional adhesion molecules; that bind to
the actin cytoskeleton directly or through the intracellular scaffolding
proteins zonula occludins (ZO).5 ZO‐1 is a cytoplasmic protein that
plays an integral role in TJ organization by linking transmembrane
components of TJs to the actin cytoskeleton.6
In the airway, TJs play an important role in restricting the move-
ment of glucose from the interstitium into the airway surface liquid
(ASL) limiting the availability of nutrients and contributing to defence
against infection.7 Inflammatory stimuli such as bacterial infections
induce changes in TJs which lead to increased permeability.8 Our
group previously showed that treatment of H441 airway epithelial
cell monolayers grown at air‐liquid interface with the biguanide met-
formin produced an increase in transepithelial electrical resistance
(TEER). We showed that this was sufficient to attenuate Staphylococ-
cus aureus‐induced increases in paracellular glucose movement across
the epithelium, in turn leading to a reduction in apical glucose accu-
mulation and diminished bacterial growth.9 This was also demon-
strated in vivo where metformin reduced glucose flux across murine
airways and a reduction in S. aureus growth.9
The effect of metformin on TEER likely reflects an alteration in TJ
composition and/or assembly but the TJ proteins involved and the sig-
nalling pathways regulating such changes are unclear. We have shown
that metformin activates AMP‐activated protein kinase (AMPK) in
H441 cells10 and other AMPK agonists such as 5‐aminoimidazole‐4‐
carboxamide‐1‐β‐D‐ribofuranoside (AICAR) 11 have also been reported
to elevate TEER in other epithelial cells.12–14 Metformin‐induced
increases in TEER in Calu3 cells were prevented with the AMPK antag-
onist Compound C,13 consistent with metformin increasing airway
epithelium TEER through an AMPK‐dependent pathway.
It has been proposed that metformin‐induced increase in AMPK
activity triggers the activation of extracellular related kinase (ERK),
phosphoinositide dependent kinase 1, and atypical protein kinase C
(aPKC) namely PKCζ and PKCλ/τ.15 How these proteins are involved
in metformin‐induced increase in TEER has not been investigated in
the airway, but evidence indicates that assembly and preservation of
TJ involves phosphorylation with Ser/Thr kinases such as PKC.16
Occludin is highly phosphorylated on its Ser/Thr residues17 which
can be readily dephosphorylated when the TJ are disrupted by cal-
cium depletion, short exposure to phorbol esters, cholesterol deple-
tion or bacterial infections.2,18–20
The aims of this study were therefore (a) to investigate the
effects of metformin on key airway epithelial TJ protein abundance;
(b) to investigate whether metformin reversed the effects of
S. aureus on TJs and (c) to identify downstream signalling molecules
involved. Identifying the proteins involved in the protective effects
of metformin on airway epithelial TJs during infection may lead to
better understanding of how glucose permeates into the ASL and
highlight potential therapeutic targets to prevent hyperglycaemia‐
induced respiratory infections.
2 | MATERIALS AND METHODS
2.1 | Cell culture
Airway epithelial cells (H441) were grown on permeable membrane
supports (Transwells, Corning, NY, USA) until confluent and then taken
to air‐liquid interface to form polarized monolayers, as previously
described.21 Monolayers were pretreated with 1 mMmetformin (phar-
macological dose to elicit changes in vitro) which was added to the
basolateral medium for 18 hours before apical addition of S. aureus. A
single colony of S. aureus strain 8325‐4 was selected and grown over-
night in 37°C in RPMI media (Life Technologies, Paisley, UK) and
diluted with glucose‐free RPMI to produce a culture of approximately
5 × 105 CFU in 50 μL this was applied to the apical surface of H441
monolayer as described previously.13 Co‐cultures were placed in a CO2
incubator at 37°C for 7 hours, after which monolayers were immunos-
tained for TJ or cell lysates were prepared for Western blot analysis.
Transepithelial electrical resistance (TEER) was measured using a
voltohmmeter (WPI, Hitchin, UK). H441 monolayers were pretreated
with protein kinase inhibitors (50 nM staurosporine or 10 μM PKC
pseudosubstrate or 80 μM Compound C were prepared in dimethyl
sulfoxide) 30 minutes prior to the addition of metformin.
2.2 | Immunofluorescence microscopy
Fully differentiated H441 at air‐liquid‐interface grown on clear tran-
swell were initially fixed with methanol:acetone for 10 minutes at
room temperature, washed with PBS. Cells were blocked and perme-
abilized with 1% bovine serum albumin containing 0.1% Triton made
up in Tris‐buffered saline. Primary antibody for ZO‐1 was a rabbit
polyclonal used at (1:100 dilution) from Thermofisher (61‐7300;
Hemel Hempstead, UK). Occludin antibody was a rabbit polyclonal
used at (1:100 dilution) from Santa Cruz Biotechnology (H‐279,
Wembley, UK). Cells were incubated at room temperature for 1 hour
washed with PBS and secondary antibody was added (anti‐rabbit
Alexa Fluor 488 at 1:100 dilution) for 30 minutes at room tempera-
ture. After rinsing with PBS transwell membranes were cut with a
clean scalpel and mounted onto slides with Vectashield mounting
medium containing 4′,6‐diamino‐2‐phenylindole (DAPI) for nuclei
staining. Images were visualized under a Zeiss LSM 510 Meta confo-
cal fluorescence microscope (Cambridge, UK).
2.3 | Western blot analysis for TJ proteins
Cell lysates were prepared by adding ERK phosphorylated buffer
containing 20 mM Tris‐HCL pH 7.5, 150 mM NaCl, 1 mM EDTA,
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50 mM NaF, 1 mM Na3VO4, 1% w/v Triton‐X, 0.5% w/v sodium
deoxycholate, 0.1% w/v SDS, 1 μg/mL protease inhibitor cocktail
(P8340; Sigma, Gillingham, UK). Cells were sonicated and debris was
removed by centrifugation at 11 180 g at 4°C for 10 minutes. Total
protein concentration was determined by Bradford Assay and
between 30 and 60 μg was electrophoresed on NuPage Novex 10%
Bis‐Tris Protein Gels (Invitrogen, Hemel Hempstead, UK). Protein
was then transferred for 70 minutes onto polvinylidene difluoride
membranes (Merck Millipore, Watford, UK). Blots were blocked in
Odyssey Blocking Buffer for 1 hour at room temperature. Blots were
incubated overnight with the following antibodies obtained from Life
Technologies and used at 1:500 dilution; mouse anti E‐Cadherin (33‐
4000), rabbit anti‐Claudin‐1 (51‐9000), and rabbit anti‐Occludin (H‐
279; Santa Cruz Biotechnology). The blots were then washed in
Tris‐buffered saline/0.2% Tween 20 and incubated with either Don-
key antimouse IgG (926‐3221; Licor, Cambridge, UK) or goat
anti‐rabbit IgG (925‐68071; Licor) for 1 hour at room temperature
and kept in the dark. Blots were subsequently probed with a
mouse monoclonal antibody to β‐actin. Detection of antigen‐
antibody complexes was assessed using a Licor Odyssey Western
blot imaging system. Integrated density of each fluorescent band
was determined, using Image Studio Lite Ver 3.1 (Licor). Results are
expressed as a ratio to β‐actin control within the same sample.
2.4 | TJ assembly after calcium depletion
Polarized H441 cell monolayers grown on 12 well transwells were
washed free of calcium with calcium free Kreb's solution containing
117 mM NaCl, 25 mM NaHCO3, 4.7 mM KCl, 1.2 mM MgSO4,
1.2 mM KH2PO4 and 5 mM glucose on both the apical and basolat-
eral compartments. Low calcium Kreb's (calcium free Krebs with 2%
Foetal calf serum, equivalent to 0.045 mM calcium from FCS) with
2 mM Ethylene-bis(oxyethylenenitrilo)tetraacetic acid (EGTA)22 was
added to both apical and basolateral compartments. TEER was mea-
sured over 20 minutes until this was reduced to ~50 Ω/cm2 from
~300 Ω/cm2. TJ re‐assembly was assessed by washing the cells free
of EGTA and adding complete media containing normal calcium con-
centration (0.42 mM) and 2% FCS. The cells were allowed to recover
for 24 hours, TJ integrity was assessed by measuring TEER and by
immunofluorescence localization of occludin. Graphic profiles of
occludin staining were created by analysing the distribution and
intensity of pixels along a chosen line, using ImageJ software (Ima-
geJ, Bethesda, MD, USA).
2.5 | Immunoprecipitation
H441 cells treated for 18 hours with 1 mM Metformin ± 10 μM
PKC pseudosubstrate were washed briefly with ice‐cold phosphate‐
buffered saline and harvested into ice‐cold lysis buffer containing
20 mM Tris‐HCL pH 7.5, 150 mM NaCl, 1 mM EDTA, 50 mM NaF,
1 mM Na3VO4, 1% w/v Triton‐X, 0.5% w/v sodium deoxycholate,
0.1% w/v SDS, 1 μg/mL protease inhibitor cocktail (P8340; Sigma).
Protein‐G Sepharose beads (Abcam, Cambridge, UK) were incubated
for 2 hours with 5 μg anti‐occludin antibodies on an orbital shaker at
4°C. Cell lysates (1.0 mg protein/mL) were added to the coated
beads and incubated overnight on an orbital shaker at 4°C. After
several washes with PBS, protein bound to the beads was eluted by
heating at 95°C for 5 minutes in Laemmli sample buffer, subjected
to Western blot analysis, immunostained with anti‐phosphoserine
(Thermo‐Scientific, Hemel Hempstead, UK) or anti‐phosphothreonine
(Thermo‐Scientific) and visualized using ECL (BioRad, Watford, UK).
2.6 | Statistical analysis
Data were analysed with Prism 4 (GraphPad, La Jolla, CA, USA) and
ImageJ softwares. Data were obtained from at least two indepen-
dent experiments and are represented as mean ± SEM. Statistical
significance was evaluated, as indicated in figure legends, using
unpaired Student's t test, one‐way ANOVA with post hoc Tukey test
and nonparametric Kruskal‐Wallace and Mann‐Whitney test when
sample size was less than 6. The alpha‐level used to determine sig-
nificance was set at P < 0.05.
3 | RESULTS
3.1 | Metformin prevents S. aureus‐induced
reduction in ZO‐1 and occludin expression at airway
epithelial TJs
To examine the effects of metformin on proteins associated with
TJs, changes in ZO‐1 localization at cellular junctions was deter-
mined by immunocytochemical analysis of H441 airway epithelial
monolayers in the presence and absence of metformin pretreatment.
Metformin treatment increased ZO‐1 expression at the TJ. Co‐cul-
ture with S. aureus led to loss of ZO‐1 at the TJ. Metformin pretreat-
ment partially attenuated the effects of bacteria on ZO‐1 expression
at the TJ (Figure 1A‐E).
Occludin is a TJ‐associated transmembrane protein that binds to
actin through its association with ZO‐1.23 Given that metformin
increased ZO‐1 expression in H441 monolayers in the presence and
absence of S. aureus, changes in occludin expression by immunocyto-
chemistry were also investigated. Similar to ZO‐1 staining, co‐culture
with S. aureus decreased occludin abundance at the cell junction.
This was not observed when cells were pretreated with metformin
(Figure 2A‐D).
3.2 | Metformin increases occludin and attenuates
S. aureus‐induced changes in abundance
Metformin increased the abundance of the 60 kD protein (consid-
ered to be full length occludin) in H441 (Figure 3B) by 41 ± 10%
(P < 0.001; n = 8). Co‐culture with S. aureus significantly reduced
the abundance of the 60 kD protein by 34 ± 10% (P < 0.05; n = 7).
This was prevented by pretreatment with metformin, which
increased occludin abundance by 54 ± 12% compared to S. aureus
(P < 0.05; n = 5) (Figure 3A). The 44 kD cleaved protein was also
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+S. aureus
Untreated +Metformin No 1° control
20 µm
F IGURE 1 H441 polarized monolayers were fixed and stained for ZO‐1 expression in the presence and absence of Staphylococcus aureus
co‐culture for 7 h. (A) Control cells no treatment. (B) Pretreatment with 1 mM metformin for 18 h. (C) In the absence of ZO‐1 antibody no
Alexa Fluor 488 fluorescence was observed. (D) Co‐culture of H441 cells with S. aureus and cells pretreated with 1 mM metformin (E). The
nuclei were counterstained with DAPI. All images were obtained at ×63 magnification. Bar = 20 μm
20 µm
Control
+S. aureus
A B
C D
F IGURE 2 H441 polarized monolayers
were fixed and stained for Occludin
expression in the presence and absence of
Staphylococcus aureus co‐culture for 7 h.
(A) Control cells no treatment. (B)
Pretreatment with 1 mM metformin for
18 h. (C) Co‐culture of H441 cells with
S. aureus and cells pretreated with 1 mM
metformin (D). The nuclei were
counterstained with DAPI. All images were
obtained at ×63 magnification.
Bar = 20 μm
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observed in our H441 lysates (Figure 3B). Both metformin and S. au-
reus significantly reduced the abundance of the 44 kD protein by
37 ± 5% and 41 ± 5% respectively (both P < 0.05; n = 4). Abun-
dance was also lowered by 42 ± 3%, P < 0.05; n = 4, in cells pre-
treatment with metformin in the presence of S. aureus (Figure 3A).
Taken together these data indicate that metformin promoted
increased abundance of the full length occludin over the 44 kD
cleavage product. Minor cleavage fragments at 46 and 38 kD were
also observed (data not shown) but their abundance did not change
significantly in the presence of S. aureus.
3.3 | Metformin and co‐culture with S. aureus had
no effect on Claudin‐1 abundance
Claudin proteins are considered to be the structural backbone of
TJs24 and critical regulators of paracellular permeability.25 Changes
in Claudin‐1 abundance, an integral transmembrane TJ protein
expressed in airway epithelium, was therefore investigated. How-
ever, neither S. aureus addition nor metformin treatment had any
effect on Claudin‐1 abundance in H441 monolayers (Figure 4A and
B).
3.4 | Metformin does not prevent the decrease in
E‐cadherin abundance produced by co‐culture with
S. aureus
In addition to occludin and claudin‐1, the cell adhesion molecule E‐
cadherin was also examined, as disruption of E‐cadherin has been
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F IGURE 3 Metformin attenuates Staphylococcus aureus induced
cleavage of occludin at 60 kD and alters cleavage fragments at
44 kD. (A) Occludin bands were normalized to β‐actin and to their
respective controls,*P < 0.05, **P < 0.01, ****P < 0.0001
significantly different from control or H441 co‐culture with S. aureus,
n = 4. (B) Western blot of H441 protein extracts of control,
S. aureus, metformin/S. aureus immunoblotted for occludin and β‐
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F IGURE 4 Differential effects of metformin and Staphylococcus
aureus on Claudin‐1 and E‐cadherin abundance. (A and B) Claudin‐1
densitometry and immunoblot normalized to β‐actin and control,
n = 3 showed no differences with treatment with 1 mM metformin
or S. aureus. (C and D) E‐cadherin densitometry and immunoblot
normalized to β‐actin and control. Co‐culture with S. aureus
significantly reduced E‐cadherin abundance which was not
prevented by the presence of metformin **P < 0.01, ***P < 0.001
****P < 0.0001, n = 13 compared to control and metformin
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shown to prevent TJ formation.26,27 Staphylococcus aureus addition
significantly reduced E‐cadherin abundance by 63 ± 3% (P < 0.0001;
n = 13) compared to control and metformin. However, metformin
had no effect on the abundance of E‐cadherin in either the presence
or absence of S. aureus (Figure 4C and D).
3.5 | Metformin‐induced increase in TEER and
occludin abundance is abrogated by PKCζ
pseudosubstrate inhibitor
To investigate the potential downstream targets of metformin that
could be involved in the changes to TEER, we used the broad‐spec-
trum protein kinase inhibitor staurosporine. Addition of 50 nM stau-
rosporine significantly reduced H441 TEER in the absence or
presence of metformin from 454 ± 20 Ω/cm2 to 218 ± 12 Ω/cm2
(P < 0.0001; n = 5, compared to control) and from 559 ± 22 to
289 ± 19 Ω/cm2 (P < 0.0001; n = 4‐5), respectively, indicating a role
for PKC isoforms in TJ formation and the generation of TEER. How-
ever, staurosporine did not prevent metformin elevation of TEER
(P < 0.05, n = 5) (Figure 5A). Staurosporine inhibits several PKC iso-
forms at this concentration but much higher concentrations of stau-
rosporine are required to inhibit PKCζ (1 μM). As staurosporine
induces apoptosis at this concentration,28 we pretreated the epithe-
lium with 10 μM PKCζ pseudosubstrate inhibitor (PSI) to test the
effects of PKCζ inhibition on airway epithelial TEER. Treatment with
PSI had no effect on H441 TEER. However, PSI prevented the met-
formin‐induced elevation of TEER (Figure 5B).
As the metformin‐induced changes in TEER were associated with
increased occludin abundance, we further explored the role of PKCζ
on occludin abundance. Treatment with PSI prevented the met-
formin‐induced increase in occludin abundance (Figure 5C) which
reflects the TEER results observed in Figure 5B.
3.6 | Metformin augments TJ reassembly and
localization of occludin to the TJ after calcium
depletion
To determine whether metformin aided the reassembly of TJs, cells
were depleted of calcium to disrupt the TJ, calcium was then
replaced and TEER was measured up to 24 hours later. Measure-
ments were normalized to TEER after 1 hour recovery as a baseline
to compare the reassembly of TJ. Metformin increased TEER and
the rise in TEER was more rapid in metformin treated than in
untreated control cells, P < 0.01, n = 8 (Figure 6A). Pretreatment of
cells with the AMPK inhibitor, Compound C or PSI prevented the
metformin‐accelerated restoration of TEER (Figure 6B).
Immunostaining of H441 cells 24 hours after calcium depletion
was carried out to analyse the abundance, and localization of occlu-
din at the TJs (Figure 6C). The intensity of occludin staining, was
analysed for pixel intensity along a linear section taking in several
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F IGURE 5 Staurosporine prevents
metformin induced increase in
transepithelial resistance (TEER). (A) H441
monolayers treated with 50 μM
staurosporine in the presence or absence
of 1 mM metformin significantly reduced
TEER compared to control and metformin
*P < 0.01, ****P < 0.0001, n = 4‐5. (B) In
the presence of 10 μM PKC‐ζ
pseudosubstrate inhibitor (PSI) TEER was
attenuated **P < 0.01 compared to
metformin, n = 6. (C) Densitometry of
occludin in protein lysates extracted from
H441 cells treated with PSI in the
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and to their respective controls, *
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cellular junctions (Figure 6D). The plots revealed an increase in peak
intensity at the TJs in metformin treated cells 38.3 ± 2.3 compared
to 25.0 ± 1.2 pixels in control, P < 0.001, n = 3. Peak intensity was
less in cells treated with metformin in the presence of PSI or Com-
pound C at 25.9 ± 3.2 and 23.6 ± 3.3 pixels (P < 0.01 and
P < 0.001, respectively, n = 3) (Figures 6D and E).
3.7 | Metformin increases Ser/Thr phosphorylation
of occludin
To determine the effect of metformin on Ser and Thr phosphoryla-
tion of occludin, protein extracts were immunoprecipitated with
occludin and immunoblotted with p‐Ser and p‐Thr. Metformin treat-
ment increased Ser/Thr phosphorylation of occludin compared to
control. PSI reduced the metformin‐induced Ser/Thr phosphorylation
of occludin to levels observed in controls (Figure 7). Treatment with
PSI did not inhibit AMPK‐mediated phosphorylation of acetyl co car-
boxylase (ACC) (phospho‐ACC/total ACC was 4.2 ± 1.3 vs 4.7 ± 1.7
in metformin vs metformin/PSI treated cells, P = 0.40, n = 4).
4 | DISCUSSION
Our data indicates that metformin increases airway epithelial TEER
by a process that involves increased ZO‐1 expression and increased
abundance and assembly of full length occludin at the TJ. Impor-
tantly metformin produced a similar effect on ZO‐1 and occludin
even in the presence of S. aureus, indicating that these proteins may
be key TJ targets for metformin action and its ability to mitigate the
effects of S. aureus on epithelial permeability.13
Epithelial barrier function is critical for host defence. It is impor-
tant for maintaining the composition and innate immune function of
µm
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F IGURE 6 Metformin enhances TEER after calcium switch in H441 cells. (A) Time course of TJ re‐assembly after calcium replacement
following depletion with 2 mM EGTA for 20 min in metformin treated and control monolayers. TEER was normalized to 1 h, **P < 0.01, n = 6
compared to control. (B) The effect of 10 μM PSI, 80 μM Compound C alone or combined with 1 mM metformin on TJ re‐assembly after
calcium depletion. TEER was measured after 24 h and normalized to 1 h, **P < 0.01, n = 3‐6 compared to control. (C) Immunofluorescence of
occludin staining before, 20 min after EGTA treatment and 24 h after EGTA was removed and replaced with regular medium containing
calcium. Monolayers were pretreated with 1 mM metformin combined with 10 μM PSI or 80 μM Compound C staining shows the disruption
of occludin after calcium depletion and reassembly 24 h later. All images were obtained at ×40 magnification. Bar = 20 μm. (D) Plots generated
using ImageJ assess the intensity of occludin staining across cell junction reassembly after 24 h EGTA treatment. (E) Mean pixel intensity of
metformin treated cells compared to control, ***P < 0.001, n = 3. Peak intensity was less in cells treated with metformin in the presence of
PSI or Compound C, **P < 0.01 and ***P < 0.001, respectively, n = 3
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the ASL and preventing access of pathogens to the internal mileu.
TJs are key to barrier function of the epithelium and comprise a
number of proteins which control the permeability of the epithelium
to ions and solutes such as glucose.29–31 It has been shown that
occludin spans the membrane four times with two extracellular loops
and that ZO‐1 interacts with the C‐terminal domain which is essen-
tial for TJ assembly.4 Pathogenic microorganisms such as S. aureus
have coat constituents such as lipoteichoic acid and express proteins
on their surfaces such as Protein A which interact with epithelial cell
surface receptors. They also release factors such as the pore forming
α‐toxin which initiate host defence mechanisms but are toxic. These
factors cause changes to epithelial cell function and can lead to
apoptosis and necrosis if bacterial load increases.32 In our study, we
found that the presence of S. aureus caused a reduction in ZO‐1, E‐
cadherin and occludin. These findings are consistent with previous
studies investigating the effects of S. aureus α‐toxin on human
intestinal epithelial cells33 and protein A on airway epithelial cells.34
In contrast, metformin increased ZO‐1 and occludin and attenuated
the reduction caused by S. aureus. These findings are similar to those
from secretory airway Calu‐3 cells infected with Pseudomonas aerugi-
nosa14 suggesting that this is a common pathway in airway epithelial
cells, affected by both gram +ve and −ve pathogens.
We observed that occludin in H441 cells presented as a protein
of ~60 kD, with cleavage products of 46, 44 and 38 kD which were
similar to that reported for Calu3 epithelial cells. A diverse range of
proteases are known to cleave junctional proteins, calpains and
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elastases have been shown to cleave occludin.35,36 There was a
reciprocal relationship between the 60 and 44 kD occludin proteins
before and after treatment with metformin indicating that metformin
promoted increased abundance of full length over cleaved occludin.
Staphylococcus aureus reduced abundance of both 60 and 44 kD
products but in the presence of metformin the full length product
was more abundant. Thus, we propose that metformin inhibited
cleavage of occludin although the process by which this occurs
requires further investigation.
Our data also indicate that metformin accelerated reassembly
of TJs after calcium depletion, as measured by the elevation in
TEER, and increased localization and abundance of occludin at the
TJ. Thus, we propose that increased abundance of full length occlu-
din and its assembly at the TJ is a critical determinant of the met-
formin‐induced elevation of TEER. Unlike Calu3 cells treated with
P. aeruginosa,14 claudin‐1 abundance was not changed in H441 cells
treated with either S. aureus or metformin which may reflect differ-
ences in cell type and/or pathogen. Other claudins were not inves-
tigated.
Metformin is known to activate AMPK in H441 cells10 and other
activators of AMPK such as AICAR have been shown to increase
TEER in airway cells,14 maintain cell polarity and barrier function.37,38
We showed that Compound C prevented the metformin‐induced rise
in TEER, TJ re‐assembly, and the increased abundance and localiza-
tion of occludin at the TJ. Although, Compound C is known to
inhibit a number of kinases in addition to AMPK,39,40 these data sup-
port a role for AMPK in the signalling pathway. We found that stau-
rosporine reduced basal TEER but did not prevent the metformin‐
induced rise in TEER. At 50 nM, staurosporine inhibits a number of
kinases, including PKC (IC50 = 3 nM),41,42 protein kinase A (IC50 = 7
nM), p60v‐src tyrosine protein kinase (IC50 = 6 nM) and CaM
kinase II (IC50 = 20 nM). In addition, staurosporine inhibits many of
the conventional and novel isoforms of PKC, including PKCα (IC50 =
2 nM), PKCγ (5 nM), PKCη (4 nM), PKCδ (20 nM) and PKCε
(73 nM). Thus, any of these kinases could be important for TJ forma-
tion but not metformin‐induced effects. Staurosporine does not inhi-
bit PKCζ at this concentration but inhibition of PKCζ with a
pseudosubstrate prevented the metformin‐induced increase in TEER,
rise in occludin abundance and assembly at TJs.
We found that PSI did not influence phosphorylation of the target
of AMPK ACC which would indicate that PKCζ acts downstream of
AMPK. Phosphorylation of liver kinase B1 by PKCζ was shown to be
necessary for metformin activation of AMPK in A549 distal airway
cells.43 However, our data is supported by evidence from heart cells
where metformin increased phosphorylation of PKCζ and that PKCζ
activity did not influence metformin phosphorylation of AMPK.44
Finally, we show that metformin increased phosphorylation of
occludin via PKCζ. We propose that this mechanism drives TJ
assembly and the resultant rise in TEER. Inhibition of phosphoryla-
tion on a number of Thr‐residues in the carboxyterminus of the pro-
tein delayed assembly of full length occludin to the TJ and disrupted
barrier function.17,18
In summary, these data indicate a metformin‐AMPK‐PKCζ depen-
dent pathway that maintains the airway epithelial barrier and assem-
bly of TJs in the face of disruption by pathogens such as S. aureus.
Our results indicate that occludin is a key target protein involved in
this process. We cannot rule out that other additional metformin‐
AMPK‐mediated effects, such as phosphorylation of G‐alpha vesicle
associated protein (GIV), also contribute to TJ formation.45 Never-
theless, as we previously showed that metformin decreased glucose
permeability across the airway epithelium, these data also implicate
occludin as an important regulator of solute (glucose) permeability
across airway epithelial TJs. Indeed, occludin has been linked to the
regulation of paracellular diffusion of small molecules.46 Thus occlu-
din and its phosphorylation by PKCζ may represent therapeutic tar-
gets for the prevention of hyperglycaemia‐associated respiratory
infections by restricting glucose flux and accumulation in the ASL
and thereby limiting the availability of glucose as a growth substrate
for bacteria.
ACKNOWLEDGEMENTS
This work was supported by a grant from the Medical Research
Council (MR/K012770/1 to DLB).
CONFLICT OF INTEREST
The authors confirm that there are no conflicts of interest.
75 kDa
50 kDa
M
ar
ke
r
Ly
sa
te
M
ar
ke
r
C
on
tr
ol
+M
F
+P
SI
+M
F/
PS
I
WB mouse
occludin
IP mouse occludin
WB rabbit p-serine
WB rabbit
occludin
IP rabbit occludin
WB mouse p-threonine
75 kDa
50 kDa
F IGURE 7 Occludin was immunoprecipitated from treated H441
cells. Monolayers were pretreated with 10 μM PSI alone or
combined with 1 mM metformin. Immunocomplexes were then
immunoblotted with phosphoserine and phosphothreonine. A
nonimmunoprecipitated control cell lysate shows occludin bands at
~60 kD and ~44 kD
KALSI ET AL. | 9
AUTHOR CONTRIBUTION
DLB, EHB, JPG and KKK designed the research study; WP, AW, JPG
and KKK performed the research; WP, AW, MED, DLB, JPG and
KKK analysed the data; DLB, JPG and KKK wrote the paper.
ORCID
Kameljit K. Kalsi http://orcid.org/0000-0002-2386-7251
James P. Garnett http://orcid.org/0000-0002-4767-020X
Emma H. Baker http://orcid.org/0000-0002-0871-3721
Deborah L. Baines http://orcid.org/0000-0001-7229-0244
REFERENCES
1. Rejman J, Di Gioia S, Bragonzi A, et al. Pseudomonas aeruginosa
infection destroys the barrier function of lung epithelium and
enhances polyplex‐mediated transfection. Hum Gene Ther.
2007;18:642‐652.
2. Kim JY, Sajjan US, Krasan GP, et al. Disruption of tight junctions dur-
ing traversal of the respiratory epithelium by Burkholderia cenocepa-
cia. Infect Immun. 2005;73:7107‐7112.
3. Van Itallie CM, Anderson JM. Claudin interactions in and out of the
tight junction. Tissue Barriers. 2013;1:e25247.
4. Cummins PM. Occludin: one protein, many forms. Mol Cell Biol.
2012;32:242‐250.
5. Fanning AS, Anderson JM. Zonula occludens‐1 and ‐2 are cytosolic
scaffolds that regulate the assembly of cellular junctions. Ann N Y
Acad Sci. 2009;1165:113‐120.
6. Fanning AS, Jameson BJ, Jesaitis LA, et al. The tight junction pro-
tein ZO‐1 establishes a link between the transmembrane protein
occludin and the actin cytoskeleton. J Biol Chem. 1998;273:29745‐
29753.
7. Malik Z, Roscioli E, Murphy J, et al. Staphylococcus aureus impairs
the airway epithelial barrier in vitro. Int. Forum Allergy Rhinol.
2015;5:551‐556.
8. Looi K, Troy NM, Garratt LW, et al. Effect of human rhinovirus infec-
tion on airway epithelium tight junction protein disassembly and
transepithelial permeability. Exp Lung Res. 2016;42:380‐395.
9. Garnett JP, Nguyen TT, Moffatt JD, et al. Proinflammatory mediators
disrupt glucose homeostasis in airway surface liquid. J. Immunol.
2012;189:373‐380.
10. Woollhead AM, Sivagnanasundaram J, Kalsi KK, et al. Pharmacologi-
cal activators of AMP‐activated protein kinase have different effects
on Na+ transport processes across human lung epithelial cells. Br J
Pharmacol. 2007;151:1204‐1215.
11. Woollhead AM, Scott JW, Hardie DG, et al. Phenformin and 5‐ami-
noimidazole‐4‐carboxamide‐1‐β‐D‐ribofuranoside (AICAR) activation
of AMP‐activated protein kinase inhibits transepithelial Na+ transport
across H441 lung cells. J Physiol. 2005;566:781‐792.
12. Myerburg MM, King JD, Oyster NM, et al. AMPK agonists
ameliorate sodium and fluid transport and inflammation in cystic
fibrosis airway epithelial cells. Am J Respir Cell Mol Biol.
2010;42:676‐684.
13. Garnett JP, Baker EH, Naik S, et al. Metformin reduces airway glu-
cose permeability and hyperglycaemia‐induced Staphylococcus aureus
load independently of effects on blood glucose. Thorax.
2013;68:835‐845.
14. Patkee WRA, Carr G, Baker EH, et al. Metformin prevents the
effects of Pseudomonas aeruginosa on airway epithelial tight junc-
tions and restricts hyperglycaemia‐induced bacterial growth. J Cell
Mol Med. 2016;20:758‐764.
15. Sajan MP, Bandyopadhyay G, Miura A, et al. AICAR and metformin,
but not exercise, increase muscle glucose transport through AMPK‐,
ERK‐, and PDK1‐dependent activation of atypical PKC. Am J Physiol
Endocrinol Metab. 2010;298:E179‐E192.
16. Stuart RO, Nigam SK. Regulated assembly of tight junctions by pro-
tein kinase C. Proc. Natl. Acad. Sci. U. S. A. 1995;92:6072‐6076.
17. Rao R. Occludin phosphorylation in regulation of epithelial tight
junctions. Ann N Y Acad Sci. 2009;1165:62‐68.
18. Jain S, Suzuki T, Seth A, et al. Protein kinase Cζ phosphorylates
occludin and promotes assembly of epithelial tight junctions. Bio-
chem. J. 2011;437:289‐299.
19. Clarke H, Soler AP, Mullin JM. Protein kinase C activation leads to
dephosphorylation of occludin and tight junction permeability
increase in LLC‐PK1 epithelial cell sheets. J Cell Sci. 2000;113(Pt
1):3187‐3196.
20. Casas E, Barron C, Francis SA, et al. Cholesterol efflux stimulates
metalloproteinase‐mediated cleavage of occludin and release of
extracellular membrane particles containing its C‐terminal fragments.
Exp Cell Res. 2010;316:353‐365.
21. Kalsi KK, Baker EH, Medina RA, et al. Apical and basolateral localisa-
tion of GLUT2 transporters in human lung epithelial cells. Pflugers
Arch. 2008;456:991‐1003.
22. McNeil E, Capaldo CT, Macara IG. Zonula occludens‐1 function in
the assembly of tight junctions in Madin‐Darby canine kidney
epithelial cells. Mol Biol Cell. 2006;17:1922‐1932.
23. Furuse M, Itoh M, Hirase T, et al. Direct association of occludin with
ZO‐1 and its possible involvement in the localization of occludin at
tight junctions. J Cell Biol. 1994;127:1617‐1626.
24. Furuse M, Sasaki H, Fujimoto K, et al. A single gene product, clau-
din‐1 or ‐2, reconstitutes tight junction strands and recruits occludin
in fibroblasts. J Cell Biol. 1998;143:391‐401.
25. Ulluwishewa D, Anderson RC, McNabb WC, et al. Regulation of
tight junction permeability by intestinal bacteria and dietary compo-
nents. J Nutr. 2011;141:769‐776.
26. Gumbiner B, Stevenson B, Grimaldi A. The role of the cell adhesion
molecule uvomorulin in the formation and maintenance of the
epithelial junctional complex. J Cell Biol. 1988;107:1575‐1587.
27. Troxell ML, Gopalakrishnan S, McCormack J, et al. Inhibiting cad-
herin function by dominant mutant E‐cadherin expression increases
the extent of tight junction assembly. J Cell Sci. 2000;113(Pt
6):985‐996.
28. Vereninov AA, Rubashkin AA, Goryachaya TS, et al. Pump and chan-
nel K (Rb+) fluxes in apoptosis of human lymphoid cell line U937.
Cell Physiol Biochem. 2008;22:187‐194.
29. Shen L, Weber CR, Raleigh DR, et al. Tight junction pore and leak
pathways: a dynamic duo. Annu Rev Physiol. 2011;73:283‐309.
30. Amasheh S. Claudin‐2 expression induces cation‐selective channels
in tight junctions of epithelial cells. J Cell Sci. 2002;115:4969‐4976.
31. Atisook K, Carlson S, Madara JL. Effects of phlorizin and sodium on
glucose‐elicited alterations of cell junctions in intestinal epithelia. Am
J Physiol. 1990;258:C77‐C85.
32. da Silva MCA, Zahm J-M, Gras D, et al. Dynamic interaction
between airway epithelial cells and Staphylococcus aureus. AJP Lung
Cell. Mol. Physiol. 2004;287:L543‐L551.
33. Kwak Y-K, Vikström E, Magnusson K-E, et al. The Staphylococcus
aureus alpha‐toxin perturbs the barrier function in Caco‐2 epithelial
cell monolayers by altering junctional integrity. Infect Immun.
2012;80:1670‐1680.
34. Soong G, Martin FJ, Chun J, et al. Staphylococcus aureus protein A
mediates invasion across airway epithelial cells through activation of
RhoA GTPase signaling and proteolytic activity. J Biol Chem.
2011;286:35891‐35898.
35. Chun J, Prince A. TLR2‐induced calpain cleavage of epithelial junc-
tional proteins facilitates leukocyte transmigration. Cell Host Microbe.
2009;5:47‐58.
10 | KALSI ET AL.
36. Nomura K, Obata K, Keira T, et al. Pseudomonas aeruginosa elastase
causes transient disruption of tight junctions and downregulation of
PAR‐2 in human nasal epithelial cells. Respir Res. 2014;15:21.
37. Zhang L, Li J, Young LH, et al. AMP‐activated protein kinase regu-
lates the assembly of epithelial tight junctions. Proc. Natl. Acad. Sci.
U. S. A. 2006;103:17272‐17277.
38. Zheng B, Cantley LC. Regulation of epithelial tight junction assembly
and disassembly by AMP‐activated protein kinase. Proc. Natl. Acad.
Sci. U. S. A. 2007;104:819‐822.
39. Zhou G, Myers R, Li Y, et al. Role of AMP‐activated protein kinase
in mechanism of metformin action. J. Clin. Invest. 2001;108:1167‐
1174.
40. Fryer LGD, Parbu-Patel A, Carling D. Protein kinase inhibitors block
the stimulation of the AMP‐activated protein kinase by 5‐amino‐4‐
imidazolecarboxamide riboside. FEBS Lett. 2002;531:189‐192.
41. Tamaoki T, Nomoto H, Takahashi I, et al. Staurosporine, a potent
inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem
Biophys Res Commun. 1986;135:397‐402.
42. Meggio F, Donella Deana A, Ruzzene M, et al. Different susceptibil-
ity of protein kinases to staurosporine inhibition. Kinetic studies and
molecular bases for the resistance of protein kinase CK2. Eur J Bio-
chem. 1995;234:317‐322.
43. Zhu H, Moriasi CM, Zhang M, et al. Phosphorylation of serine 399
in LKB1 protein short form by protein kinase C is required for its
nucleocytoplasmic transport and consequent AMP‐activated protein
kinase (AMPK) activation. J Biol Chem. 2013;288:16495‐16505.
44. Ussher JR, Jaswal JS, Wagg CS, et al. Role of the atypical protein
kinase Czeta in regulation of 5′‐AMP‐activated protein kinase in car-
diac and skeletal muscle. Am J Physiol Endocrinol Metab. 2009;297:
E349‐E357.
45. Aznar N, Patel A, Rohena CC, et al. AMP‐activated protein kinase
fortifies epithelial tight junctions during energetic stress via its effec-
tor GIV/Girdin. Elife. 2016;5:e20795.
46. Balda MS, Whitney JA, Flores C, et al. Functional dissociation of
paracellular permeability and transepithelial electrical resistance and
disruption of the apical‐basolateral intramembrane diffusion barrier
by expression of a mutant tight junction membrane protein. J Cell
Biol . 1996;134:1031‐1049.
How to cite this article: Kalsi KK, Garnett JP, Patkee W,
et al. Metformin attenuates the effect of Staphylococcus
aureus on airway tight junctions by increasing PKCζ‐mediated
phosphorylation of occludin. J Cell Mol Med. 2018;00:
1–11. https://doi.org/10.1111/jcmm.13929
KALSI ET AL. | 11
